Genetic Susceptibility to Cancer


Overview

The Epidemiology and Genomics Research Program (EGRP) is a strong supporter of epidemiology studies investigating genetic susceptibility to cancer across all populations, including family studies, candidate gene studies, genome-wide association studies (GWAS), and use of next generation sequencing techniques to identify variants associated with specific cancers. Such studies have identified many genetic variants that may be associated with cancer.

To further our understanding of cancer etiology and outcomes, the Program also supports studies to determine the function of identified cancer risk variants associated with specific cancers, especially in high risk or under-served populations. EGRP is also interested in research investigating gene-gene and gene-environment interactions and the integration of germline and somatic information as it contributes to understanding of cancer etiology and outcomes.

Return to Top

Selected Projects

EGRP staff manage and provide technical assistance for several grant-supported initiatives and research resource contracts in the area of genomic epidemiology. Examples of significant past initiatives include:

Return to Top

Funding Opportunities

Funding Opportunity Announcements

NCI-sponsored Funding Opportunity Announcements (FOAs) related to genetic epidemiology include:

  • Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes – expires May 8, 2020, unless reissued
  • Genomic Community Resources (U24) – expires January 26, 2020, unless reissued
  • Ethical, Legal, Social Implications of Human Genome Research – expires September 8, 2020, unless reissued
  • Exploratory Grants in Cancer Epidemiology and Genomics Research - expires May 8, 2019, unless reissued

EGRP also encourages investigator-initiated grant applications on genetic susceptibility to cancer. See also EGRP’s interests in biomarkers, gene-environment research and metabolomics in population-based studies. It also joins with other NCI Divisions, and other components of the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs.

Return to Top

Research Resources

Return to Top

Webinars and Workshops

EGRP co-sponsors webinars, seminars, and workshops to convene experts in the fields of cancer epidemiology and genetics research to review the state of the science, identify research gaps, and establish scientific agendas and priorities for the future, such as:

Upcoming Events

Past Events

Return to Top

Contacts

Charlisse Caga-anan, J.D. – Ethics of genetics and genomics research, health law and bioethics

Danielle Carrick, Ph.D., M.H.S. - Immunology, infectious diseases, and autoimmune diseases associated with cancer risk; pharmacoepidemiology and pharmacogenomics; biospecimen research; functional genomics

Danielle Daee, Ph.D. - Genetic susceptibility to cancer

Elizabeth M. Gillanders, Ph.D. - Genetic epidemiology of cancer

Damali N. Martin, Ph.D., M.P.H. - Cancer epidemiologic research and disparities in underserved populations, global health and cancer epidemiology, cancer registry development in the Carribean

Leah E. Mechanic, Ph.D., M.P.H. - Gene-gene and gene-environment interactions; biospecimen science; molecular epidemiology of lung cancer, hematological malignancies, and endometrial cancer

Stefanie A. Nelson, Ph.D. - Genetic differences affecting cancer risk and response to treatment, understanding the function of cancer risk variants, and interactions between the germline and somatic cancer genomes

Melissa Rotunno, Ph.D. – Genetic epidemiology of lung cancer, breast cancer, melanoma, and Hodgkin's lymphoma; application of new analytical methods in genomics; pleiotropic effects in cancer susceptibility; next-generation sequencing in cancer epidemiology

Krista A. Zanetti, Ph.D., M.P.H., R.D. - Metabolomics, -omics data integration

Return to Top